在转移性 fumarate hydratase-deficient 细胞癌中准代谢和表观遗传重编程
Nadja Kührer1, Irene Huebner-Resch2, Roman Mayr3
1Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
Clinical & experimental metastasis
|August 8, 2025
概括
酸盐酸酶缺乏性细胞癌 (FHdRCC) 是一种侵袭性癌症. 新兴的向疗法对先进的FHdRCC有希望,将治疗转向个性化医学.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 酸盐酸酶缺乏性细胞癌 (FHdRCC) 是一种罕见但具有攻击性的恶性瘤.
- 它具有很高的转移潜力和不良预后,需要新的治疗策略.
- 2022年世界卫生组织分类现在将FHdRCC归类为细胞癌的分子定义亚型.
研究的目的:
- 审查正在进行的高级/转移性FHdRCC的临床试验.
- 突出潜在的分子机制,包括代谢和表观遗传重编程,以及亲瘤信号.
- 讨论FHdRCC新兴的向治疗策略.
主要方法:
- 审查目前的第二阶段临床试验,评估向治疗组合.
- 对治疗结果的分析,包括客观反应率 (ORR).
- 讨论新疗法准的FHdRCC的分子基础.
主要成果:
- 目前正在研究多种向治疗组合,包括免疫检查点抑制剂,多氨酸激酶抑制剂和PARP抑制剂.
- 有希望的组合显示出高的客观响应率:尼沃卢马布/卡博赞提尼布 (100%),伦瓦提尼布/提斯莱利祖马布 (93.3%),贝瓦西祖马布/埃洛提尼布 (72%) 和辛蒂利马布/阿克西替尼布 (63.1%).
- 这些结果强调了向药物的潜力,用于管理先进的FHdRCC.
结论:
- 向疗法,特别是组合疗法,在先进的FHdRCC中表现出显著的疗效.
- 了解代谢和表观遗传重编程对于开发新型治疗策略至关重要.
- 针对特定信号通路的个性化医疗方法有望改善转移性FHdRCC的结果.
关键词:
贝瓦西祖马布 (bevacizumab) 是一种药物.埃尔洛提尼布 (Erlotinib) 是一种药物.富马酸酸酶是什么意思?富马酸酸酶缺乏的细胞癌.遗传性肌瘤和细胞癌免疫治疗是一种免疫疗法.细胞癌 (RCC) 是一种细胞癌.有针对性的治疗.更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.7K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.5K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Mitogens and the Cell Cycle
6.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.7K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
